CTIS.eu › Cities › Netherlands › 's-Gravenhage
's-Gravenhage
Netherlands
151 total trials
72 recruiting
2022-501100-94-00
5
2023-11-08
Episodic Migraine
2023-505277-32-00
5
2023-01-26
Diffuse Large B-Cell Lymphoma (DLBCL)
2023-505749-14-00
5
2022-03-20
c-Met overexpressing EGFR wildtype non-squamous non-small cell lung ca
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
2025-522007-18-00
5
2026-05-27
Relapsed or Refractory Multiple Myeloma
2024-516993-31-00
5
2026-05-11
Renal Cell Carcinoma
2025-524366-21-00
5
2026-04-29
treatment-naive Chronic Lymphocytic Leukemia
2025-521316-19-00
6
2026-04-20
Urolithiasis
2023-505556-21-00
5
2026-03-12
cocaine use disorder
2025-521117-88-00
5
2026-03-11
Cardiovascular Disease
2025-523692-39-00
5
2026-03-11
locally advanced rectal cancer
2024-516356-18-00
5
2026-02-17
Atherosclerotic cardiovascular disease (ASCVD)
2025-521692-31-00
5
2025-12-19
Chronic Primary Immune Thrombocytopenia
2025-523083-21-00
5
2025-12-08
PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor
2024-514401-54-00
5
2025-11-13
Chronic Primary Immune Thrombocytopenia
2023-509175-16-00
5
2025-10-14
Sickle cell disease
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
2025-521377-14-00
4
2025-10-06
Atrial fibrillation
2024-513836-28-00
5
2025-06-23
Chronic Migraine
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
2024-517343-31-00
6
2025-04-11
Ischemic stroke and transient ischemic attack
2024-516068-27-01
5
2025-04-10
status epilepticus
2025-520540-15-00
4
2025-01-27
aneurysmal subarachnoid hemorrhage
2024-512950-13-00
11
2025-01-03
Sepsis
Showing 25–48 of 151 trials